farmaco

1 articoli

Salute /

Covid: Toscana Life Sciences, a marzo pronto il farmaco con gli anticorpi monoclonali

Al via la sperimentazione su un campione di volontari. Lo scienziato Rappuoli: “Cura complementare al vaccino entro i primi mesi del 2021”

intoscana
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.